Event in Progress:
Discover the latest content that has just been published on Research Tree
Ebro did slightly better than the guidance given three months ago. The year was clearly driven by the first half, the third and fourth quarters having encountered many challenges which are expected to continue in FY23. Despite this, it can be said that Ebro does not feel too bad about the situation.
Companies: Ebro Foods (EBRO:BME)Ebro Foods SA (EBRO:MCE)
Ebro had held up well up to this point but we were not that surprised to see a relatively poor Q3. The group is facing a lot of pressures that are likely to continue in the coming months.
Easy comps have driven up the H1 results, but the environment remains tight and Ebro expects lower H2 demand which should in the end not help the rest of the year.
A strong performance in Q1 (better-than-expected) is welcomed given the more cautious tone of the company for the following months.
9m FY21 figures were obviously down vs. FY20 (strong negative comps), but they were still remarkable compared with FY19. We expected very complicated management of inflation for the group, but we see a rather good surprise on that side. On the other hand, we should be more cautious about 2022, when the current hedging will roll off.
Unsurprisingly, we see a decrease in the results compared to 2020, but still good progress compared to 2019, which confirms the good trajectory of the group.
With no surprise, Q1 FY21 top and bottom lines declined due to tough comps. The momentum remains, however, strong looking at CAGR 21/19, but input cost inflation is now the main threat looking forward.
Unsurprising very strong FY20 results (but still even more than our expectations). We believe Ebro is at a turning point and we continue to be positive on the stock.
Although the figures showed greater volatility, the rise in demand triggered by the COVID-19 pandemic continues to dominate Ebro’s results. Deleveraging is well on track.
Companies: Ebro Foods SA
After a strong set of FY19 figures, Ebro’s Q1 benefited from COVID-19 due to increasing rice and pasta consumption. Q2 should be even better, while we expect a gradual return to normal starting in Q3. EBITDA is affected by raw material prices increase, but the group is confident that the FY20 bottom line should be better yoy.
A strong set of FY19 figures, especially thanks to strong comparables. We note that organic investments had begun to bear fruit, although the company doesn’t expect to see the relevant impacts until 2021. In the mean time, it is actually debt that is going up.
The group reported a strong set of Q3 FY19 results, beating analysts’ expectations on the bottom line. Ebro’s investments finally pushed up growth… as well as the group’s debt.
FY18 Key Financials :
Group sales grew by 5.6% to €2,464m (on organic basis: +2%)
EBITDA fell by 13.4% to €311m, with currency having a negative impact of €4.4m
EBITDA margin declined by 2.6 pp to 11.7%. In Q4: 14% EBITDA margin
Net profit fell by 36% to €142m, while the FY17 net profit was positively driven by the tax-related measures approved in the USA, France and Italy (one-off extraordinary income of €56.5m). Excluding this external effect, net profit fell by 14%
FY18 Net debt/EBITDA
Q3 update: Sales are up 11%, however, the EBITDA margin contracted by 340bp due to the Rice business which was impacted by higher raw material prices (mainly in North America) as well as a weaker Pasta performance and higher logistics costs in the US.
By division, Rice recorded +16% in sales and a 516bp EBITDA margin contraction to 9.2%. Pasta recorded +7% in sales and a 316bp EBITDA margin contraction to 9.8% (in Europe, Pasta consumption was negatively impacted by the hot weather, the group e
H1 update: revenue grew by 2.3% (+5.5% in Q2), whereas EBITDA contracted by 16.6%. The EBITDA margin stood at 11.2%.
By division, the Rice business’s sales were up +2.6% in Q2, whereas the EBITDA margin contracted vs. Q1 to 12%.
In Pasta, sales were up +8% in Q2 (partially helped by easier comps) while the EBITDA margin stood at 11.1% (vs. 11.8% in Q1).
Net profit for the period is down 17.1%.
Research Tree provides access to ongoing research coverage, media content and regulatory news on Ebro Foods SA.
We currently have 19 research reports from 2
MP Evans has delivered another strong year driven by an excellent crop and production performance and the continuing strength of the CPO price. However, profits are a tad below our top-of-range forecasts due to higher-than-expected cost pressures, namely fertiliser and the cost of buying in fresh fruit bunches (FFB), but cashflow and the dividend is better than forecast. Current trading is encouraging with production performance and the CPO price ahead of our assumptions. FY22 cashflow performan
Companies: M.P. Evans Group PLC
Chapel Down is a market leader, which is asset backed and offers multiple years of high growth. This is evidenced by FY22 finals with adj. PBT +22% to £1.7m. A generational shift to the growing popularity of English sparkling wine and premiumisation trends make for an attractive investment case. We forecast PBT to more than double by FY26 from the current asset base. Thereafter, our illustrative analysis shows deployment of new capital towards attaining 5% of the addressable market by FY32 (vs 2
Companies: Chapel Down Group plc
Singer Capital Markets
30 January 2023
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment object
Companies: EDEN PGH FIF AVG INSE RDT SPE CHAR BXP
01 February 2023
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objec
Companies: ADRO AXL TIDE WYN PEG RST KWS KIBO 1128 ORCA
Companies: Cranswick plc
Companies: Celadon Pharmaceuticals PLC
Carr’s Group has released its audited results for FY22, having previously issued a detailed trading update in February giving preliminary financial metrics on FY22 performance. The shares were suspended from trading in January because of delays in publishing these results. The company has applied for them to be restored to trading.
Companies: Carr's Group PLC
01 March 2023
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectiv
Companies: ARV OHG NICL MBT GETB CRCL HAYD HARL
Companies: Cake Box Holdings Plc
Anpario’s full year results are in line with expectations, following a strong and improved H2. The group is still in a transition phase, building strong commercial relationships with end users and appointing regional teams, and we believe the group will continue to grow as a result. Anpario currently trades on a 2017 EV/EBITDA of 11.7x, going to 10.8x in 2018. We feel this is an undeserved discount to its peer group (c.17.8x 2017 EV/EBITDA). We remain at Buy.
Companies: Anpario plc
Anpario’s full year results highlighted a period of strong growth with momentum reportedly continuing into 2018. The group remains focused on building strong commercial relationships with end users and we expect the initiatives to help the group deliver our 11% sales growth estimate in 2018. We make modest adjustments to our forecasts this morning and increase our Target Price by 2p to 434p. We remain at Hold.
Companies: TXP CWK ARBB TON FA/ BEG IGC VLS BWNG HUW WINK INSE BAG GPH NRR OTMP BONH GSF EPWN SUR KP2 MMAG FBH GNC EML KAPE AMYT
Companies: A.G. BARR p.l.c.